Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. InfuScience, Inc. dba Bioscrip Infusion Services
483
•InfuScience, Inc. dba Bioscrip Infusion Services•July 30, 2019

InfuScience, Inc. dba Bioscrip Infusion Services – FDA 483, Jul 30, 2019

Record Details

An FDA inspection of InfuScience, Inc. dba Bioscrip Infusion Services, a producer of sterile drug products in Chantilly, VA, was conducted from July 23-30, 2019. The inspection revealed eight observations regarding the facility's sterile drug production practices.

Observation 1 noted inadequate segregation, cleaning of work surfaces, and cleaning of utensils to prevent cross-contamination of beta-lactam drugs. Specific instances included producing a non-beta-lactam product after beta-lactam production without proper cleaning, and producing a beta-lactam product in the same ISO 5 hood as unsealed non-beta-lactam vials.

Observation 2 identified visibly dirty equipment or surfaces in ISO 5 classified aseptic processing areas, specifically "white staining" on rear HEPA filters of laminar air flow hoods, which were not cleaned before or between aseptic processing of products, including Total Parenteral Nutrition (TPN).

Observation 3 detailed personnel blocking first pass air during aseptic manipulations. This occurred when technicians manipulated sterile connections, with IV bags or equipment blocking the exposed sterile connection from first pass air in the ISO 5 classified area.

Observation 4 cited personnel not disinfecting and changing gloves frequently enough. Technicians reached into trash receptacles and touched surfaces outside the ISO 5 area without sanitizing or changing gloves before resuming aseptic processing.

Observation 5 stated that materials and supplies were not disinfected prior to entering aseptic processing areas.

Company
InfuScience, Inc. dba Bioscrip Infusion Services
Inspection date
July 30, 2019
Product type
Drugs
Office
Baltimore District Office
Person
  • Sena G. Dissmeyer
View Company Profile

ID · 00812eb7-7d71-4037-ab90-f6c649b99091

Other documents for InfuScience, Inc. dba Bioscrip Infusion Services
  • 483 - 2021-10-08October 8, 2021
  • WARNING_LETTER - 2019-07-30July 30, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore InfuScience, Inc. dba Bioscrip Infusion Services
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.